Stock UniverseDerived research view · source repositories remain read-only

Zevra Therapeutics, Inc. (ZVRA)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Watch
Selection Score
30.51
Global Rank
1892
Market Cap
502.74M
Latest Close
10.61
RS Composite
4.13% · G#1066

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-5.69%
3M
18.15%
6M
21.67%
1Y
18.55%
3Y
110.52%
5Y
3.61%
10Y
-90.65%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.12M · 30-day average: 1.73M · Max drawdown over stored range: -97.85%

Research Snapshot

Relative Strength vs SPX

RS Composite4.13%
20D RS-4.18%
60D RS-7.05%
120D RS19.46%
Global RS Rank1066 · 68.23% percentile
Watch+Speculative RS Rank678 · 67.67% percentile
Group ScopeWatch+Speculative
Primary RS Rank118 · 74.24% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank268 / 701
Primary Percentile61.91
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-06n/an/a-5.43M124.22M2.15-7.28M1.18M-8.46M58Mn/an/an/an/an/a95.59M61.93M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$2.154.9xn/an/a$-0.15-72.5x$-0.13-84.3x

Shares Diluted: 58M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue13.28828.6510.16127.46123.612106.47
Revenue Growth (YoY)3.497%115.608%-64.534%170.259%-14.016%350.915%
Gross Profit11.98326.5919.93925.28816.195
Operating Income-4.7817.729-24.902-49.604-87.003
Free Cash Flow-1.97210.337-18.81-33.831-69.665-2.433
Free Cash Flow Per Share-0.4950.347-0.545-0.954-1.506-0.04248838009165301
EPS (Diluted) GAAP-3.21-2.113023-0.776252-1.298894-2.281257
EPS Growth
EPS Non-GAAP
Gross Margin90.179%92.813%97.815%92.087%68.588%84.5196%
Operating Margin-35.98%26.977%-245.074%-180.634%-368.469%-59.1181%
Profit Margin-96.026%-219.536%-263.478%-167.689%-446.853%78.1713%
Free Cash Flow Margin-14.84%36.08%-185.12%-123.197%-295.041%-2.2852%
Shares Outstanding (Diluted)3.98129.766334.488835.452546.251257.2627
Shares Change (YoY)114.793%647.715%15.865%2.794%30.46%23.808%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-06n/an/a52.15Mn/a37.89Mn/a0.6060.23M95.59M61.93Mprocessed
2025 Q42026-03-09n/an/a9.31Mn/a12.16Mn/a0.2158.70M62.41M61.93Mprocessed
2025 Q32025-11-05n/an/a4.14Mn/a-544.00Kn/a-0.0155.95M54.44M61.31Mprocessed
2025 Q22025-08-12n/an/a-71.04Mn/a74.71Mn/a1.2156.32M47.71M60.69Mprocessed
2025 Q12025-05-13n/an/a-5.36Mn/a-3.10Mn/an/an/a37.34M60.09Mprocessed
2024 Q42025-03-12n/an/a-15.42Mn/a-35.74Mn/an/an/a33.78M59.50Mprocessed
2024 Q32024-11-13n/an/a-27.31Mn/a-33.23Mn/an/an/a54.04M58.90Mprocessed
2024 Q22024-08-14n/an/a-23.80Mn/a-19.93Mn/an/an/a39.26M58.33Mprocessed
2024 Q12024-05-09n/an/a-20.49Mn/a-16.62Mn/an/an/a42.85Mn/aprocessed
2023 Q42024-04-01n/an/a-14.67Mn/a-15.15Mn/an/an/a43.05Mn/aprocessed
2023 Q32023-11-07n/an/a-15.36Mn/a-14.04Mn/an/an/a43.27Mn/aprocessed
2023 Q22023-08-14n/an/a-6.64Mn/a-5.08Mn/an/an/a66.20Mn/aprocessed
2023 Q12023-05-15n/an/a-12.92Mn/a-11.77Mn/an/an/a40.18Mn/aprocessed
2022 Q42023-03-07n/an/a-9.25Mn/a-9.02Mn/an/an/a65.47M7.60Mprocessed
2022 Q32022-11-10n/an/a-6.63Mn/a-6.62Mn/an/an/a75.89M69.40Mprocessed
2022 Q22022-08-12n/an/a-24.77Mn/a-24.04Mn/an/an/a80.98M69.40Mprocessed
2022 Q12022-05-12n/an/a-1.86Mn/a-1.86Mn/an/an/a101.58M69.40Mprocessed
2021 Q42022-03-31n/an/a-2.84Mn/a-2.70Mn/a-0.0835.35M112.35M69.40Mprocessed
2021 Q32021-11-10n/an/a-2.22Mn/a-1.76Mn/a-0.0635.22M131.50M69.40Mprocessed
2021 Q22021-08-13n/an/a5.83Mn/a6.20Mn/a-0.4029.17M132.29M69.40Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.